Recent publications from Alliance investigators are delivering practice-changing insights that directly improve patient care. Featured in leading journals—including the New England Journal of Medicine, Journal of Clinical Oncology, and JAMA Oncology—these studies are shaping treatment strategies for prostate cancer, meningioma, lung cancer, and colon cancer. Below is a selection of these recent publications. Journal of…
At the Alliance, we share stories that highlight the progress and impact of cancer research. By highlighting new clinical trials, scientific discoveries, and the achievements of our investigators, we shine a light on the progress being made against cancer and the people driving it forward. These stories raise awareness of the essential role clinical trials…
A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to new study in JAMA Oncology. Based on data from an Alliance for Clinical Trials in Oncology study, this finding could lead to more personalized treatments and better outcomes for patients. Colon cancer…
Today, the Alliance for Clinical Trials in Oncology was informed that the U.S. Food and Drug Administration has approved cabozantinib for the treatment of patients with previously treated advanced neuroendocrine tumors (NETs). NETs are a type of cancer that manifest characteristics of both nerve and hormone-producing cells, and can arise in various parts of the…